Celularity Inc filed a Form D with the Securities and Exchange Commission on 2025-08-05.
Celularity Inc filed a Form D notice of an exempt securities offering with the SEC on August 5, 2025. The filing reports $2M sold. Its industry group is Biotechnology. It names Robert Hariri (Chief Executive Officer and Chairman of the Board of Directors), John Haines (Senior Executive Vice President, Chief Administrative Officer and Corporate Secretary), Joseph DosSantos (Chief Financial Officer) (SEC Form D, August 5, 2025).
Is this your company?
Sell to companies like Celularity Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-08-05 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Celularity Inc.
Free to see. No signup.
More on the people and the money behind Celularity Inc, from the filings we hold.
Biotechnology raises by companies based in New Jersey, filed within 90 days of this one, largest first.
Get an email when Celularity Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Celularity Inc raises, hires or launches. No email unless you switch it on.
Watch Celularity Inc →Get the full cited report on Celularity Inc
What the filing shows about Celularity Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Celularity Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Celularity Inc's address as 170 Park Avenue, Florham Park, NJ 07932.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Celularity Inc is a registered filer with the SEC (CIK 1752828) and has filed since 2025-08-05. 4 filings are on record, the latest on 2025-11-03.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Celularity Inc's Form D of 2025-08-05 names Robert Hariri, John Haines, Joseph DosSantos and 5 more as its officers, directors or promoters.
Its new offerings report $11.85M sold across 4 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 769 filings in Biotechnology, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer, Director.
Robert Hariri is named as Chief Executive Officer and Chairman of the Board of Directors on the Form D that Celularity Inc filed with the SEC on 5 August 2025, one of 8 people that filing names.
On the filing as: Executive Officer.
John Haines is named as Senior Executive Vice President, Chief Administrative Officer and Corporate Secretary on the Form D that Celularity Inc filed with the SEC on 5 August 2025, one of 8 people that filing names.
On the filing as: Executive Officer.
Joseph DosSantos is named as Chief Financial Officer on the Form D that Celularity Inc filed with the SEC on 5 August 2025, one of 8 people that filing names.
On the filing as: Executive Officer.
Stephen Brigido is named as President, Degenerative Disease on the Form D that Celularity Inc filed with the SEC on 5 August 2025, one of 8 people that filing names.
Peter Diamandis is named as Director on the Form D that Celularity Inc filed with the SEC on 5 August 2025, one of 8 people that filing names.
Vincent LeVien is named as Director on the Form D that Celularity Inc filed with the SEC on 5 August 2025, one of 8 people that filing names.
Geoffrey Ling is named as Director on the Form D that Celularity Inc filed with the SEC on 5 August 2025, one of 8 people that filing names.
Diane Parks is named as Director on the Form D that Celularity Inc filed with the SEC on 5 August 2025, one of 8 people that filing names.
8 people named on the filing — 4 holding an executive role and 4 as directors only.
Named as of the 2025-08-05 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Celularity Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Celularity Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Celularity Inc covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Celularity IncYou get an alert in MentionFox the next time this company shows up.
If you're behind Celularity Inc: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-01 (celularity.com).
Each opens in a new tab, filled in for Celularity Inc. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Northern New Jersey
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/celularity-inc-form-d-25000004